Breakthrough developments in rheumatology treatment is changing the lives for patients and prompt more inclusive underwriting terms related to the spectrum of conditions associated with rheumatism.

In an interview published in La Tribune, SCOR Chairman & CEO Denis Kessler reflects on the Covid-19 pandemic, its impact on the (re)insurance industry and the lessons to be learned from this exceptional h

Eric Lecoeur, SCOR's Group Chief Actuary, along with Alexandre Boumezoued, R&D Director at Milliman France, discuss in an article published in The Actuary how to invest for successful R&D.